NCT06282588 2026-03-19
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
Clinical Trials
6 trialsNCT06009627 2026-02-10
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Completed
NCT04209868 2024-03-29
ParaSOL
Guy's and St Thomas' NHS Foundation Trust
Phase 2/3 Unknown
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed
NCT05280444 2022-12-29
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
Zhongda Hospital
Phase 2/3 Unknown
NCT01333293 2016-01-18
XOLMA
University of Zurich
Phase 2/3 Completed